• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

Rare cases of stroke reported with alemtuzumab

December 14, 2018  

Early diagnosis of MS – is it a myth?

November 28, 2018  

Effect of MS treatment on cognitive dysfunction

November 15, 2018  

Overview of long-term data in RRMS

November 7, 2018  

Oral cladribine recommended for public reimbursement in Canada

November 6, 2018  

ECTRIMS 2018 SLIDE DECK

October 25, 2018  

ECTRIMS 2018 DAILY REPORT – FRIDAY EDITION

October 12, 2018  

ECTRIMS Poster Picks – Friday, October 12

October 12, 2018  

ECTRIMS 2018 DAILY REPORT – THURSDAY EDITION

October 11, 2018  

ECTRIMS Poster Picks – Thursday, October 11

October 11, 2018  
Previous
23
24
25
26
27
Next

Browse by Topic

  • MS (442)
  • EAN 2026 (2)
  • CLINICAL CASES (21)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • EPILEPSY (38)
  • AES 2025 (1)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Anti-CD20 therapy in MS: comparing efficacy and safety posted on July 21, 2026
  • Highlights of EAN 2026 – Part 1 posted on June 30, 2026
  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions